AstraZeneca sells the rights to two hypertension drugs in $400M deal
November 02, 2020 at 13:38 PM EST
AstraZeneca will get $250 million when the deal closes and another $150 million by the middle of next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|